HIV-seropositive individuals' optimistic beliefs about prognosis and relation to medication and safe sex adherence

Journal of General Internal Medicine

Volumn 17, Issue 9, 2002, Pages 677-683

  Holmes, William C ^a   Pace, Joseph L ^a  

^a Center for Clinical Epidemiology and Biostatistics   (United States)

Author keywords

AIDS; HIV; Patient compliance; Prognosis; Sex behavior

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DRUG USE; EDUCATION; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; LIFE EXPECTANCY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PERCEPTION; PROGNOSIS; RACE DIFFERENCE; SAFE SEX; SELF REPORT; SENESCENCE; SERODIAGNOSIS; T LYMPHOCYTE;

ADULT; DATA COLLECTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV; HIV SEROPOSITIVITY; HUMANS; LIFE EXPECTANCY; MALE; PATIENT COMPLIANCE; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; SAFE SEX; SELF ASSESSMENT (PSYCHOLOGY); SOCIOECONOMIC FACTORS;

EID: 0036042806     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.2002.00746.x     Document Type: Article

References (26)

1. When plagues end
2. New optimism on controlling HIV infection
3. HIV/AIDS care calls for reallocation of resources
4. AIDS as a clinically curable disease: The growing optimism
5. The eral of adherence to HIV therapy
6. Living with HIV infection: Adaptive tasks of seropositive gay men
7. Rethinking nonadherence: Historical perspectives on triple-drug therapy for HIV disease
8. A randomized, doubleblind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: The INCAS Trial
9. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy
10. Births and deaths: United States, 1996
11. Treatment with indinivir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
12. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
13. Race, gender, drug use, and participation in AIDS clinical trials
14. Update: Trends in AIDS incidence-United States, 1996
15. Summary of notifiable diseases, United States, 1998
16. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS
17. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
18. Reliability and validity of self-report CD4 counts in persons hospitalized with HIV disease
19. Intravenous drug use and the immune system
20. HIV-1 protease inhibitors: A review for clinicians
21. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study
22. The impact of competing subsistence needs and barriers on access to medical care for persons with HIV receiving care in the United States